We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MEDICA Health IT Forum 2023 to Highlight General Digitalization Trends

By LabMedica International staff writers
Posted on 13 Oct 2023

This year, the MEDICA HEALTH IT FORUM will once again be a part of the renowned international medical trade fair MEDICA (Düsseldorf, Germany) scheduled for 13-16 November 2023. More...

The MEDICA HEALTH IT FORUM is a platform for innovations where attendees can experience top-class talks and sessions on the way to data-driven healthcare. In addition, there will be topic-related exhibits from leading universities and research institutions in the adjoining exhibition area, providing a comprehensive and tangible picture of digitally-optimized medicine.

The MEDICA HEALTH IT FORUM 2023 will bundle expertise and the latest developments and the pioneers of the industry will themselves be present. The forum 2023 will include expert panels with a keynote, followed by a series of statements and a panel discussion, as well as Q&A, a series of complementary tech talks, and open mic for exhibitor lectures & demonstrations. The complete program of the MEDICA HEALTH IT FORUM is as follows:

Monday, 13 November 2023

  • Drug discovery with AI
  • Quantum computing
  • Circularity in healthcare
  • Gamification
  • Female doctorpreneurship
  • Open mic

Tuesday, 14 November 2023

  • Predictive analytics
  • Healthcare metaverse
  • Chat GPT & Co.
  • Smart textiles
  • TikTok, Insta & Co. - Engaging, learning and networking on social media platforms
  • Green Hospital
  • Open mic

Wednesday, 15 November 2023

  • Data spaces & platforms
  • Consumer health
  • Safe AI
  • Circadian health
  • Digital empowerment
  • Open mic

Thursday, 16 November 2023

  • Digital mental health
  • Automation in healthcare / RPA
  • Health tech for the elderly
  • Medical education & digitization
  • Nutrition
  • Open mic

Related Links:
MEDICA


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Steam Sterilizer
Hi Vac II Line
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The integrated polygenic risk score combines information from multiple genetic variants into a single test that provides a result for each of eight cardiovascular conditions (photo credit: Adobe Stock)

Genomic Risk Score Identifies Inherited Risk for Multiple Cardiovascular Conditions

Cardiovascular disease is the leading cause of death worldwide, yet many at‑risk individuals are overlooked by traditional calculators. Tools that weigh age, sex, blood pressure, and cholesterol can miss... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.